Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 July 2021 | Story Ruan Bruwer | Photo UFS Photo Archive

Two athletes, both employees of the University of the Free State (UFS), are now giving back to the sport in administrative roles.

Kesa Molotsane and Louzanne Coetzee are making time in their work and training schedules to serve the sports in which they have represented their country – Molotsane in cross-country and Coetzee in the 1 500 m and 800 m T11 category for athletes with a disability.

Louzanne_web content
Louzanne Coetzee Photo: UFS Photo Archive 

Coetzee is again heading for the Paralympic Games in Tokyo. She is a nominee for the International Paralympic Committee Athletes’ Council. Six representatives will be chosen at the Paralympics.

Coetzee was recently elected to the South African Sports Confederation and Olympic Committee Athletes’ Commission. She is also an athlete representative of the South African Sports Association for Physically Disabled.

Molotsane was co-opted into the National Executive Committee of University Sport South Africa as an assessor. She is also the new vice-chairperson of the Athletics South Africa Athletes Commission.

Kesa Molotsane_content
Kesa Molotsane. Photo: Supplied

“My biggest dream is to enable athletes to dream big, and for their dreams to be recognised. I would like to see them enjoy their sport,” said Molotsane.

“I think I probably missed a lot of opportunities in my career due to a lack of funding, so I don’t want to see anyone face the same situation.”

Molotsane was also recently named as one of two ambassadors for the SPAR Grand Prix Series. 

According to Coetzee, a former member of the Student Representative Council at the UFS, she believes that it is important for a current sportsperson to contribute and give input in their sport. 

“I enjoy leadership, it is perhaps a gift of mine. Serving the sport in that capacity is not something that is too much of an effort or takes too much of my time. I enjoy contributing and to see something move in a direction.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept